Rankings
▼
Calendar
OCGN Q3 2024 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena
OCGN
Ocugen, Inc.
$578M
Q3 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1M
-69.3% YoY
Gross Profit
$1M
100.0% margin
Operating Income
-$13M
-1166.5% margin
Net Income
-$13M
-1141.7% margin
EPS (Diluted)
$-0.05
QoQ Revenue Growth
-0.4%
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$12M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$62M
Total Liabilities
$21M
Stockholders' Equity
$41M
Cash & Equivalents
$39M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1M
$4M
-69.3%
Gross Profit
$1M
-$3M
+133.9%
Operating Income
-$13M
-$12M
-6.6%
Net Income
-$13M
-$12M
-10.7%
← FY 2024
All Quarters
Q4 2024 →